Desjardins Global Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $2.48M | Buy |
42,868
+459
| +1% | +$26.5K | 0.27% | 79 |
|
|
2023
Q3 | $2.24M | Buy |
42,409
+9,541
| +29% | +$504K | 0.24% | 81 |
|
|
2023
Q2 | $1.78M | Buy |
32,868
+22,120
| +206% | +$1.2M | 0.2% | 114 |
|
|
2023
Q1 | $538K | Buy |
10,748
+6,346
| +144% | +$318K | 0.07% | 234 |
|
|
2022
Q4 | $203K | Buy |
4,402
+52
| +1% | +$2.4K | 0.03% | 341 |
|
|
2022
Q3 | $168K | Buy |
4,350
+145
| +3% | +$5.6K | 0.02% | 357 |
|
|
2022
Q2 | $156K | Sell |
4,205
-171
| -4% | -$6.34K | 0.02% | 362 |
|
|
2022
Q1 | $193K | Sell |
4,376
-266
| -6% | -$11.7K | 0.02% | 358 |
|
|
2021
Q4 | $197K | Buy |
+4,642
| New | +$197K | 0.02% | 364 |
|